Erle T. Mast, Executive VP and CFO at Clovis Oncology, Inc. (CLVS), sold 3,000 shares at $85.23 ($258K) on 2015-08-03, disclosed to the SEC on 2015-08-05.
Scheduled sale ($258k) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.23 | 1,190 | $101K | 39.3% |
| 2 | $86.33 | 1,310 | $113K | 43.8% |
| 3 | $86.81 | 500 | $43K | 16.8% |
| Total | $85.97 avg | 3,000 | $258K | 100% |
| Filing → |
| SNNA | BUY | 2017-08-01 | $101K | — | Filing → |
| CLVS | SELL | 2015-11-03 | $317K | — | Filing → |
| CLVS | SELL | 2015-10-02 | $271K | — | Filing → |